Articles

Results 1 to 5 of 43


Spotlight: competition law in the pharmaceutical sector in USA

USA - September 7 2022 This article reviews the application of competition law principles to the pharmaceutical sector in USA, with particular regard to the merger control regime and anticompetitive behaviour.

Deborah L Feinstein, Abigail Struthers, Matthew Tabas

A general introduction to pharmaceutical IP and competition issues in USA

USA - September 7 2022 This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in USA, with particular regard to recent developments.

Deborah L Feinstein, Abigail Struthers, Matthew Tabas

Q&A: marketing authorisation for pharmaceuticals and medical devices in USA

USA - October 20 2021 This article answers some of the key legal and practical questions surrounding the grant of marketing authorisation for pharmaceuticals and medical devices in USA.

Q&A: the promotion and sale of pharmaceuticals and medical devices in USA

USA - October 20 2021 This Q&A covers the essential legal and practical considerations surrounding the promotion and sale of pharmaceuticals and medical devices in USA.

A general introduction to pharmaceutical IP and competition issues in USA

USA - September 30 2021 This article examines the most consequential features of the IP and competition law frameworks in relation to the pharmaceutical sector in USA, with particular regard to recent developments.

David K. Barr, Deborah L Feinstein, Peter J Levitas